The effectiveness of this S-1 activates a standing equity line of credit, meaning the company can now draw down cash by issuing new shares to C/M Capital, who will resell them into the market. This creates persistent downward pressure on the stock as the market absorbs potential share sales. Monitor for any 8-K announcing an initial drawdown — that would signal immediate dilution. The company's distressed financials (going concern, delisting risk) make this a high-risk equity story.
Price Chart
Executive Summary
The SEC declared effective the S-1 registration statement (File No. 333-298112) for Endovia Health Sciences, Inc. (formerly Splash Beverage Group, Inc.), enabling the resale of up to 10,000,000 shares of common stock by its ELOC provider C/M Capital Master Fund. This is a procedural step that activates the company's equity line of credit, creating a persistent dilution overhang given the company's distressed financial position (going-concern opinion, minimal cash, negative equity, and NYSE American delisting risk).
Key Facts
- Effectiveness date: August 24, 2026, for S-1 registration statement (File No. 333-298112).
- Registration covers up to 10,000,000 shares of common stock for resale by C/M Capital Master Fund, LP.
- Shares are issuable under an ELOC agreement dated September 19, 2025, with up to $32,164,892 in potential gross proceeds to the company.
- Company has a going-concern opinion, only $330K cash, negative stockholders' equity, and is under NYSE American delisting risk.
- Company transitioned from beverage sales to cannabinoid/wellness and was formerly named Splash Beverage Group, Inc.
Financial Impact
Up to 10,000,000 shares of common stock may be sold into the market by the ELOC provider, representing significant potential dilution. The company could receive up to $32.16M in gross proceeds from future drawdowns, but has only $330K cash on hand and negative equity.
Risk Factors
- Immediate dilution risk as the ELOC provider can sell shares into the market at any time.
- Company has a going-concern opinion, minimal cash ($330K), and negative stockholders' equity.
- NYSE American delisting risk adds uncertainty to the trading venue and liquidity.
- The company's pivot to cannabinoid/wellness from beverages adds execution risk with no proven revenue stream.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002743 |
| Document: 9999999995-26-002743-index.html | 9999999995-26-002743 |
| Document: 9999999995-26-002743.txt | 9999999995-26-002743 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | SC 13G | $0.1600 $0.1577 | ▼ −1.44% | ▼ −2.15% | $0.1580 (−1.25%) |
Oct 15, 2026 11d ago | 8-K | $0.1460 $0.1350 | ▲ +7.53% | ▲ +7.96% | $0.1580 (−8.22%) |
Oct 6, 2026 20d ago | 8-K | $0.1650 $0.1599 | ▲ +3.09% | ▲ +2.67% | $0.1580 (+4.24%) |
Oct 5, 2026 21d ago | DEF 14A | $0.1679 $0.1650 | ▲ +1.73% | ▲ +1.49% | $0.1580 (+5.90%) |
Oct 5, 2026 21d ago | 8-K | $0.1680 $0.1650 | ▼ −1.79% | ▼ −1.55% | $0.1580 (−5.95%) |
Aug 31, 2026 8w ago | 8-K | $0.2954 $0.2614 | ▼ −11.51% | ▼ −11.95% | $0.1580 (−46.51%) |
Aug 25, 2026 8w ago | EFFECT | $0.4182 $0.3650 | ▲ +12.72% | ▲ +12.74% | $0.1580 (+62.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers